Book Value per Share: CorMedix Inc (CRMD)

Graphic logo of CorMedix Inc. (CRMD)

CorMedix Inc. (CRMD) focuses on developing antimicrobial agents, outsourcing production to third-party plants. This model allows the team to remain agile, minimizing capital expenditures by outsourcing trials. This price trend visualization on GURU.Markets shows the metric at 5.94. However, financial stability relies on the success of a single drug in US dialysis centers, which creates significant risks due to a lack of portfolio diversification.

CorMedix Inc (CRMD): Share Book Value from 07/04/2022 to 10/28/2026

cormedix.com - analytical breakdowns and key metrics (CRMD)

- price and consensus price forecast:
Price Chart CorMedix Corp|CRMD - Consensus Target
- market capitalization data:
Market Capitalization CorMedix Inc.|CRMD - Business Value
- book capitalization data:
Net Assets per Single Share CorMedix|CRMD - Net Asset Value|Market Capitalization to Book Value Ratio cormedix.com|CRMD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital CorMedix Inc.|CRMD - Long-Term Debt to Capital|Short-Term Debt to Equity CorMedix|CRMD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio CorMedix Inc.
Fundamental company valuation:CorMedix Corp - CRMD
Manufactured products of CorMedix

The automation of Defencath sterile filling using AI control optimizes the capital expenditures of CorMedix Inc. (CRMD). This indicator is calculated as the ratio of equity to the number of shares, determining the actual value of net assets. An analysis of the book value per common share allows for the filtering of market noise to reveal the actual accumulation of resources. The upward trend of the curve confirms the efficiency of investments in line robotization. The stability of this metric ensures capital protection against the fundamental devaluation of the business.

Competitors of CorMedix Inc. (CRMD)

SMMT: Net Assets per Single Share|MRNA - Accounting Value per Share|Book Value per Share Vaxcyte, Inc.|TARS (tarsusrx.com) - Equity per Share|Net Assets per Single Share Seres Therapeutics, Inc. MCRB|Share Book Value Spero Therapeutics Inc|SCYNEXIS, Inc. (SCYX) - Book Value per Share|Accounting Value of a Share an2therapeutics.com (ANTX)|Book Value per Share PYPD (PolyPid)|ysbiopharm.com - Book Value per Share|Net Assets per Single Share Iterum Therapeutics, plc (ITRM)|PHGE: Accounting Value of a Share|SNGX (soligenix.com) - Net Assets per Single Share|60 Degrees Pharmaceuticals, Inc. (SXTP) - Accounting Value per Share|OGEN (Oragenics) - Book Value per Share|Book Value per Share onconetix.gcs-web.com (ONCO)|OpGen (OPGN) - Accounting Value per Share